1. Use of serological tests to reduce the risk of transmission of Trypanosoma cruzi infection in blood and blood components Publication: Silver Spring, MD : Center for Biologics Evaluation and Research, December 2017 Subject(s): Blood DonorsChagas Disease -- bloodChagas Disease -- transmissionDisease Transmission, Infectious -- prevention & controlDonor SelectionSerologic TestsTrypanosoma cruziChagas Disease -- prevention & controlRisk ManagementHumansUnited StatesUnited States. Department of Health and Human Services.United States. Food and Drug Administration.
2. Further testing of donations that are reactive on a licensed donor screening test for antibodies to hepatitis C virus Publication: Silver Spring, MD : Center for Biologics Evaluation and Research, October 2019 Subject(s): Blood -- virologyBlood Banks -- standardsBlood DonorsHepatitis C -- bloodHepatitis C -- transmissionDonor SelectionHepatitis C Antibodies -- bloodNucleic Acid Amplification TechniquesHumansUnited StatesUnited States. Department of Health and Human Services.United States. Food and Drug Administration.
3. Implementation of acceptable full-length and abbreviated donor history questionnaires and accompanying materials for use in screening donors of blood and blood components: guidance for industry Publication: Silver Spring, MD : Center for Biologics Evaluation and Research, May 2023 Subject(s): Blood DonationBlood DonorsDonor SelectionGovernment RegulationMandatory TestingSurveys and QuestionnairesUnited States
4. Recommendations for evaluating donor eligibility using individual risk-based questions to reduce the risk of human immunodeficiency virus transmission by blood and blood products: guidance for industry Publication: Silver Spring, MD : Center for Biologics Evaluation and Research, May 2023 Subject(s): Blood DonationBlood DonorsBlood TransfusionDonor SelectionGovernment RegulationHIV Infections -- prevention & controlMandatory TestingUnited States
